147 related articles for article (PubMed ID: 17579625)
21. Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.
Tagami-Nagata N; Serada S; Fujimoto M; Tanemura A; Nakatsuka R; Ohkawara T; Murota H; Kishimoto T; Katayama I; Naka T
Exp Dermatol; 2015 Nov; 24(11):864-71. PubMed ID: 26173926
[TBL] [Abstract][Full Text] [Related]
22. Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma.
Li Z; Metze D; Nashan D; Müller-Tidow C; Serve HL; Poremba C; Luger TA; Böhm M
J Invest Dermatol; 2004 Oct; 123(4):737-45. PubMed ID: 15373779
[TBL] [Abstract][Full Text] [Related]
23. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
24. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation.
Venkataraman C; Leung S; Salvekar A; Mano H; Schindler U
J Immunol; 1999 Apr; 162(7):4053-61. PubMed ID: 10201928
[TBL] [Abstract][Full Text] [Related]
25. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
[TBL] [Abstract][Full Text] [Related]
26. Loss of interferon-induced Stat1 phosphorylation in activated T cells.
Van De Wiele CJ; Marino JH; Whetsell ME; Vo SS; Masengale RM; Teague TK
J Interferon Cytokine Res; 2004 Mar; 24(3):169-78. PubMed ID: 15035850
[TBL] [Abstract][Full Text] [Related]
27. Lack of STAT 1 phosphorylation at TYR 701 by IFNgamma correlates with disease outcome in melanoma patients.
Boudny V; Dusek L; Adámková L; Chumchalová J; Kocak I; Fait V; Lauerová L; Krejcí E; Kovarík J
Neoplasma; 2005; 52(4):330-7. PubMed ID: 16059651
[TBL] [Abstract][Full Text] [Related]
28. Cross-inhibition of interferon-induced signals by GM-CSF through a block in Stat1 activation.
Kasper S; Kindler T; Sonnenschein S; Breitenbuecher F; Böhmer FD; Huber C; Fischer T
J Interferon Cytokine Res; 2007 Nov; 27(11):947-59. PubMed ID: 18052729
[TBL] [Abstract][Full Text] [Related]
29. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
31. Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation.
Kovarik J; Boudny V; Kocak I; Lauerova L; Fait V; Vagundova M
Int J Mol Med; 2003 Sep; 12(3):335-40. PubMed ID: 12883649
[TBL] [Abstract][Full Text] [Related]
32. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
33. Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α.
Tomita S; Ishibashi K; Hashimoto K; Sugino T; Yanagida T; Kushida N; Shishido K; Aikawa K; Sato Y; Suzutani T; Yamaguchi O
Cancer Sci; 2011 Jan; 102(1):57-63. PubMed ID: 21054677
[TBL] [Abstract][Full Text] [Related]
34. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes.
Story DJ; Stephens JM
Obesity (Silver Spring); 2006 Aug; 14(8):1303-11. PubMed ID: 16988072
[TBL] [Abstract][Full Text] [Related]
35. Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling.
Dickensheets H; Vazquez N; Sheikh F; Gingras S; Murray PJ; Ryan JJ; Donnelly RP
Genes Immun; 2007 Jan; 8(1):21-7. PubMed ID: 17093501
[TBL] [Abstract][Full Text] [Related]
36. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.
Vlotides G; Sörensen AS; Kopp F; Zitzmann K; Cengic N; Brand S; Zachoval R; Auernhammer CJ
Biochem Biophys Res Commun; 2004 Jul; 320(3):1007-14. PubMed ID: 15240148
[TBL] [Abstract][Full Text] [Related]
37. Negative regulation of onconstatin M signaling by suppressor of cytokine signaling (SOCS-3).
Magrangeas F; Boisteau O; Denis S; Jacques Y; Minvielle S
Eur Cytokine Netw; 2001; 12(2):309-15. PubMed ID: 11399520
[TBL] [Abstract][Full Text] [Related]
38. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.
Respa A; Bukur J; Ferrone S; Pawelec G; Zhao Y; Wang E; Marincola FM; Seliger B
Clin Cancer Res; 2011 May; 17(9):2668-78. PubMed ID: 21248298
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
[TBL] [Abstract][Full Text] [Related]
40. Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma.
Gollob JA; Sciambi CJ; Huang Z; Dressman HK
Cancer Res; 2005 Oct; 65(19):8869-77. PubMed ID: 16204058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
